Oestrogen receptor negative breast cancers exhibit high cytokine content

被引:275
|
作者
Chavey, Carine
Bibeau, Frederic
Gourgou-Bourgade, Sophie
Burlinchon, Sandrine
Boissiere, Florence
Laune, Daniel
Roques, Sylvie
Lazennec, Gwendal
机构
[1] Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France
[2] CRLC Val Aurelle, Dept Pathol, F-34298 Montpellier, France
[3] CRLC Val Aurelle, Biostat Unit, F-34298 Montpellier, France
[4] Ctr Pharmacol & Biotechnol Sante, Fac Pharm, CNRS, UMR 5160, F-34093 Montpellier, France
关键词
D O I
10.1186/bcr1648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction An emerging hypothesis suggests that cytokines could play an important role in cancer as potential modulators of angiogenesis and leucocyte infiltration. Methods A novel multiplexed flow cytometry technology was used to measure the expression of 17 cytokines ( IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [CSF], granulocyte-macrophage CSF, IFN-gamma, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1 beta, tumour necrosis factor [TNF]-alpha) at the protein level in 105 breast carcinoma. B lymphocyte, T lymphocyte and macrophage levels were determined by immunohistochemistry. Results Fourteen of the 17 cytokines were expressed in breast carcinoma, whereas only nine cytokines could be detected in normal breast. Most cytokines were more abundant in breast carcinoma than in normal breast, with IL-6, IL-8, granulocyte CSF, IFN-gamma, MCP-1 and MIP-1 beta being very abundant. IL-2, IL-6, IL-8, IL-10, IFN-gamma, MCP-1, MIP-1 beta and TNF-alpha, and to a lesser extent IL-1 beta and IL-13 exhibited levels of expression that were inversely correlated to oestrogen receptor and progesterone receptor status. Most cytokines were not correlated with age at cancer diagnosis, tumour size, histological type, or lymph node status. However, IL-1 beta, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1 beta were more abundant in high-grade tumours than in low-grade tumours. In addition, IL-8 and MIP-1 beta were expressed to a greater degree in HER2-positive than in HER2-negative patients. The expression of most of the studied cytokines was correlated to levels of activator protein-1, which is known to regulate numerous cytokines. Overexpression of MCP-1 and MIP-1 beta were linked to B lymphocyte, T lymphocyte and macrophage infiltration, whereas high levels of IL-8 were correlated with high macrophage content in tumour. Moreover, IL-8 positive tumours exhibited increased vascularization. Conclusion We found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines - MCP-1, MIP-1 beta and IL-8 - were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
    Hannah Harrison
    Bruno M Simões
    Lynsey Rogerson
    Sacha J Howell
    Göran Landberg
    Robert B Clarke
    Breast Cancer Research, 15
  • [42] Age specific variation of oestrogen and progesterone receptor expression in 1340 primary operable breast cancers
    Neven, P.
    Huang, H. J.
    Drijkoningen, M.
    Armant, F.
    Berteloot, P.
    Van Limbergen, E.
    Thomas, J.
    Paridaens, R.
    Vergote, I.
    Christiaens, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 177 - 178
  • [43] Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
    Hilborn, Erik
    Gacic, Jelena
    Fornander, Tommy
    Nordenskjold, Bo
    Stal, Olle
    Jansson, Agneta
    BRITISH JOURNAL OF CANCER, 2016, 114 (03) : 248 - 255
  • [44] Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
    Harrison, Hannah
    Simoes, Bruno M.
    Rogerson, Lynsey
    Howell, Sacha J.
    Landberg, Goeran
    Clarke, Robert B.
    BREAST CANCER RESEARCH, 2013, 15 (02):
  • [45] DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers
    H Iwase
    Y Omoto
    H Iwata
    T Toyama
    Y Hara
    Y Ando
    Y Ito
    Y Fujii
    S Kobayashi
    British Journal of Cancer, 1999, 80 : 1982 - 1986
  • [46] DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers
    Iwase, H
    Omoto, Y
    Iwata, H
    Toyama, T
    Hara, Y
    Ando, Y
    Ito, Y
    Fujii, Y
    Kobayashi, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (12) : 1982 - 1986
  • [47] A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women
    J. Murray
    O. E. Young
    L. Renshaw
    S. White
    L. Williams
    D. B. Evans
    J. St. J. Thomas
    M. Dowsett
    J. M. Dixon
    Breast Cancer Research and Treatment, 2009, 114 : 495 - 501
  • [48] A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women
    Murray, J.
    Young, O. E.
    Renshaw, L.
    White, S.
    Williams, L.
    Evans, D. B.
    Thomas, J. St. J.
    Dowsett, M.
    Dixon, J. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 495 - 501
  • [49] Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
    Erik Hilborn
    Jelena Gacic
    Tommy Fornander
    Bo Nordenskjöld
    Olle Stål
    Agneta Jansson
    British Journal of Cancer, 2016, 114 : 248 - 255
  • [50] Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
    Ricardo Ribas
    Zara Ghazoui
    Qiong Gao
    Sunil Pancholi
    Aradhana Rani
    Anita Dunbier
    Mitch Dowsett
    Lesley-Ann Martin
    Breast Cancer Research, 16